Showing 200 results
- Featured News /
Latest news and interviews for media and investors
- Pulse Update /
- Featured News /Annual meeting highlights progress on the company’s transformation and growth strategy.
- Featured News /Novartis announced the company’s financial results for the third quarter of 2020.
- Featured News /
Novartis poised to expand impact on human health as it begins next era.
- Featured News /
- Statement /
- Statement /
- Featured News /
- Statement /
Novartis and BeiGene, Ltd. have mutually agreed to terminate the collaboration and license agreement for tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody.
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 20
- › Next page